Loading stock data…
GNW
$9.06-0.07 (-0.77%)
Market ClosedLast close May 11
Genworth Financial, Inc., together with its subsidiaries, provides mortgage and long-term care insurance products in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Genworth Financial, Inc. in the Financial Services sector is trading at $9.06. The stock is currently near its 52-week high of $9.45, remaining 5.3% above its 200-day moving average. Technical signals show neutral RSI of 61 and bullish MACD crossover, explaining why GNW maintains its current momentum and trend strength. The Whystock Score of 70/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 61) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$9.06
Potential Upside
12.6%
Whystock Fair Value$10.20
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Genworth Financial, Inc., together with its subsidiaries, provides mortgage and long-term care insurance products in the United States. It operates through two segments: Enact and Closed Block. The company offers primary mortgage, and mortgage insura...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.44B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
16.44
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.00
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.55%
Volume
Today's trading volume
1.22M
Recent News
Will Genworth's (GNW) Softer Q1 Results and Buybacks Reframe Its Capital Allocation Narrative?
Genworth Financial reported past first-quarter 2026 results with revenue of US$1,777 million and net income of US$47 million, alongside earnings per share of US$0.12, all slightly lower than a year earlier. The company also advanced its capital return and growth plans, completing over 5% in share repurchases under its 2025 buyback, while highlighting Enact’s contribution and expansion of its Care Scout platform. Next, we’ll examine how Genworth’s continued share repurchases and capital...
Genworth Financial Q1 Earnings Call Highlights
Genworth Financial (NYSE:GNW) reported first-quarter 2026 net income of $47 million and adjusted operating income excluding its Closed Block segment of $109 million, as management emphasized continued cash generation from Enact Holdings, investment in CareScout and efforts to manage legacy long-term
Genworth (GNW) Q1 2026 Earnings Transcript
In addition to our speakers, Jamala Arland, President and CEO of our Closed Block Insurance business, Greg Caruana, General Counsel, Kelly Saltsgeber, Chief Investment Officer, and Samir Shah, CEO of CareScout, will also be available to take your questions. For the first quarter, Genworth Financial, Inc. reported net income of $47 million with adjusted operating income, excluding the closed block, of $109 million.
Genworth Financial, Inc. Q1 2026 Earnings Call Summary
Moby summary of Genworth Financial, Inc.'s Q1 2026 earnings call
How Investors May Respond To Genworth Financial (GNW) Flat Q4 Results And Completed Share Buyback
In February 2026, Genworth Financial reported fourth-quarter 2025 results showing essentially flat revenue at US$1,784 million year over year and a shift from a small net loss to a modest US$2 million profit, while full-year earnings declined despite slightly higher revenue. The company also completed a buyback of 10,327,981 shares for US$90.02 million, underlining management’s focus on capital returns alongside investment in businesses like Enact and CareScout. We’ll now examine how the...